Angela Huttner - Concepedia

Author

Angela Huttner

University Hospital of Geneva

Also Known As

Angela Huttner, Huttner, Angela, Patricia Fast

Publications

977

Citations

H-Index

Concepts

All Affiliations

University Hospital of Geneva Universitätsklinikum Tübingen German Center for Infection Research Universität Hamburg University Medical Center Hamburg-Eppendorf

About

Angela Huttner is an author at University Hospital of Geneva specializing in immunology, vaccination, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	6	186
2	Immunology	3	6	186
3	Epidemiology	1	1	79
4	Humoral Immunity	1	1	39
5	Immunodominance	1	1	39

Angela Huttner

Publications

735

Citations

H-Index

Page 1

	Year	Citations
Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe Sélidji Todagbé Agnandji, Angela Huttner, Madeleine E. Zinser, New England Journal of Medicine	2015	404
Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study Angela Huttner, Sélidji Todagbé Agnandji, Christophe Combescure, The Lancet Infectious Diseases VaccinationSingle-dose Rvsv-zebov VaccinationAntibody PersistenceImmunologyVirology	2018	79
Dose-dependent T-cell Dynamics and Cytokine Cascade Following rVSV-ZEBOV Immunization Christine Dahlke, Rahel Kasonta, Sebastian Lunemann, EBioMedicine	2017	77
A Simulation-Based Assessment of Strategies to Control Clostridium Difficile Transmission and Infection Michael Rubin, Makoto Jones, Molly Leecaster, PLoS ONE	2013	53
An Economic Analysis of Strategies to Control Clostridium Difficile Transmission and Infection Using an Agent-Based Simulation Model Richard E. Nelson, Makoto Jones, Molly Leecaster, PLoS ONE	2016	47
Detectable Vesicular Stomatitis Virus (VSV)–Specific Humoral and Cellular Immune Responses Following VSV–Ebola Virus Vaccination in Humans Joseph H Poetsch, Christine Dahlke, Madeleine E. Zinser, The Journal of Infectious Diseases VaccinationCandidate VaccineMucosal VaccinationVaccine DevelopmentVsv Vector	2018	39
Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccination David Pejoski, Casimir de Rham, Paola Martinez-Murillo, npj Vaccines	2020	19
Antibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across doses and continents: 5-year durability Angela Huttner, Sélidji Todagbé Agnandji, Olivier Engler, Clinical Microbiology and Infection VaccinationEbola Virus DiseaseMucosal VaccinationVaccine DevelopmentVaccine Target	2023	17

Page 1